Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × DNA × Myeloid × Clear all

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

fludarabine 32 Cyclophosphamide 28 venetoclax 27 Azacitidine 26 Specimen Handling 23 Biopsy 20 Cytarabine 17 fludarabine phosphate 15 ruxolitinib 14 Decitabine 14 Whole-Body Irradiation 13 Melphalan 12 Stem Cell Transplantation 11 Injections 11 Busulfan 11 Tacrolimus 10 Mycophenolic Acid 8 Methotrexate 8 decitabine and cedazuridine drug combination 7 asciminib 7 Thiotepa 7 Granulocyte Colony-Stimulating Factor 7 Magnetic Resonance Spectroscopy 6 Idarubicin 6 Hematopoietic Stem Cell Transplantation 6 tagraxofusp 5 nilotinib 5 X-Rays 5 Filgrastim 5 Daunorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05605379 2024-08-14

CML Piramid

University Hospital, Bordeaux

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡